Three-dimensional microscopy characterization of death receptor 5 expression by over-activated human primary CD4 + T cells and apoptosis

PLoS ONE

Volumn 7, Issue 3, 2012, Pages

  Barblu, Lucie ^a   Herbeuval, Jean Philippe ^a  

^a CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DEATH RECEPTOR 5; MESSENGER RNA; PHYTOHEMAGGLUTININ; SMALL INTERFERING RNA; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND RECEPTOR;

APOPTOSIS; ARTICLE; CD4+ T LYMPHOCYTE; CELL MEMBRANE; CELL NUCLEUS; CONTROLLED STUDY; CYTOPLASM; HUMAN; HUMAN CELL; IMMUNE RESPONSE; LYMPHOCYTE ACTIVATION; MICROSCOPY; NORMAL HUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN SECRETION; STAINING; THREE DIMENSIONAL MICROSCOPY; UPREGULATION; CELL CULTURE; FLUORESCENCE MICROSCOPY; GENE EXPRESSION; GENE SILENCING; GENETICS; IMMUNOLOGY; METABOLISM; RNA INTERFERENCE;

APOPTOSIS; CD4-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; GENE EXPRESSION; GENE SILENCING; HUMANS; LYMPHOCYTE ACTIVATION; MICROSCOPY, FLUORESCENCE; PHYTOHEMAGGLUTININS; RECEPTORS, TNF-RELATED APOPTOSIS-INDUCING LIGAND; RNA INTERFERENCE;

EID: 84857862604     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0032874     Document Type: Article

References (43)

1. Russell JH, (1995) Activation-induced death of mature T cells in the regulation of immune responses. Curr Opin Immunol 7: 382-388.
2. Nagata S, (1996) Fas-mediated apoptosis. Adv Exp Med Biol 406: 119-124.
3. Cohen JJ, (1993) Apoptosis. Immunol Today 14: 126-130.
4. Nagata S, Golstein P, (1995) The Fas death factor. Science 267: 1449-1456.
5. Nagata S, (1994) Fas and Fas ligand: a death factor and its receptor. Adv Immunol 57: 129-144.
6. Pan G, O'Rourke K, Chinnaiyan AM, Gentz R, Ebner R, et al. (1997) The receptor for the cytotoxic ligand TRAIL. Science 276: 111-113.
7. Golstein P, (1997) Cell death: TRAIL and its receptors. Curr Biol 7: R750-753.
8. Wiley SR, Schooley K, Smolak PJ, Din WS, Huang CP, et al. (1995) Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity 3: 673-682.
9. Schneider P, Schwenzer R, Haas E, Muhlenbeck F, Schubert G, et al. (1999) TWEAK can induce cell death via endogenous TNF and TNF receptor 1. Eur J Immunol 29: 1785-1792.
10. Griffith TS, Chin WA, Jackson GC, Lynch DH, Kubin MZ, (1998) Intracellular regulation of TRAIL-induced apoptosis in human melanoma cells. J Immunol 161: 2833-2840.
11. Herbeuval JP, Lambert C, Sabido O, Cottier M, Fournel P, et al. (2003) Macrophages From Cancer Patients: Analysis of TRAIL, TRAIL Receptors, and Colon Tumor Cell Apoptosis. J Natl Cancer Inst 95: 611-621.
12. Gura T, (1997) How TRAIL kills cancer cells, but not normal cells. Science 277: 768.
13. Griffith TS, Lynch DH, (1998) TRAIL: a molecule with multiple receptors and control mechanisms. Curr Opin Immunol 10: 559-563.
14. Sheikh MS, Burns TF, Huang Y, Wu GS, Amundson S, et al. (1998) p53-dependent and-independent regulation of the death receptor KILLER/DR5 gene expression in response to genotoxic stress and tumor necrosis factor alpha. Cancer Res 58: 1593-1598.
15. Sheridan JP, Marsters SA, Pitti RM, Gurney A, Skubatch M, et al. (1997) Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors. Science 277: 818-821.
16. Wu GS, Burns TF, McDonald ER 3rd, Jiang W, Meng R, et al. (1997) KILLER/DR5 is a DNA damage-inducible p53-regulated death receptor gene. Nat Genet 17: 141-143.
17. Sato K, Hida S, Takayanagi H, Yokochi T, Kayagaki N, et al. (2001) Antiviral response by natural killer cells through TRAIL gene induction by IFN-alpha/beta. Eur J Immunol 31: 3138-3146.
18. Tecchio C, Huber V, Scapini P, Calzetti F, Margotto D, et al. (2004) IFNalpha-stimulated neutrophils and monocytes release a soluble form of TNF-related apoptosis-inducing ligand (TRAIL/Apo-2 ligand) displaying apoptotic activity on leukemic cells. Blood 103: 3837-3844.
19. Ehrlich S, Infante-Duarte C, Seeger B, Zipp F, (2003) Regulation of soluble and surface-bound TRAIL in human T cells, B cells, and monocytes. Cytokine 24: 244-253.
20. Martinez-Lorenzo MJ, Anel A, Gamen S, Monle n I, Lasierra P, et al. (1999) Activated human T cells release bioactive Fas ligand and APO2 ligand in microvesicles. J Immunol 163: 1274-1281.
21. Bosque A, Pardo J, Martinez-Lorenzo MJ, Lasierra P, Larrad L, et al. (2005) Human CD8+ T cell blasts are more sensitive than CD4+ T cell blasts to regulation by APO2L/TRAIL. Eur J Immunol 35: 1812-1821.
22. Bosque A, Pardo J, Martinez-Lorenzo MJ, Iturralde M, Marzo I, et al. (2005) Down-regulation of normal human T cell blast activation: roles of APO2L/TRAIL, FasL, and c- FLIP, Bim, or Bcl-x isoform expression. J Leukoc Biol 77: 568-578.
23. Walczak H, Miller RE, Ariail K, Gliniak B, Griffith TS, et al. (1999) Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo. Nat Med 5: 157-163.
24. Ichikawa K, Liu W, Zhao L, Wang Z, Liu D, et al. (2001) Tumoricidal activity of a novel anti-human DR5 monoclonal antibody without hepatocyte cytotoxicity. Nat Med 7: 954-960.
25. Griffith TS, Broghammer EL, (2001) Suppression of tumor growth following intralesional therapy with TRAIL recombinant adenovirus. Mol Ther 4: 257-266.
26. Griffith TS, (2009) Induction of tumor cell apoptosis by TRAIL gene therapy. Methods Mol Biol 542: 315-334.
27. Griffith TS, Stokes B, Kucaba TA, Earel JK Jr, VanOosten RL, et al. (2009) TRAIL gene therapy: from preclinical development to clinical application. Curr Gene Ther 9: 9-19.
28. Wahl H, Tan L, Griffith K, Choi M, Liu JR, (2007) Curcumin enhances Apo2L/TRAIL-induced apoptosis in chemoresistant ovarian cancer cells. Gynecol Oncol 105: 104-112.
29. Griffith TS, Anderson RD, Davidson BL, Williams RD, Ratliff TL, (2000) Adenoviral-mediated transfer of the TNF-related apoptosis-inducing ligand/Apo-2 ligand gene induces tumor cell apoptosis. J Immunol 165: 2886-2894.
30. Smyth MJ, Takeda K, Hayakawa Y, Peschon JJ, van den Brink MR, et al. (2003) Nature's TRAIL-on a path to cancer immunotherapy. Immunity 18: 1-6.
31. Newsom-Davis T, Prieske S, Walczak H, (2009) Is TRAIL the holy grail of cancer therapy? Apoptosis 14: 607-623.
32. Herbeuval JP, Boasso A, Grivel JC, Hardy AW, Anderson SA, et al. (2005) TNF-related apoptosis-inducing ligand (TRAIL) in HIV-1-infected patients and its in vitro production by antigen-presenting cells. Blood 105: 2458-2464.
33. Herbeuval JP, Grivel JC, Boasso A, Hardy AW, Chougnet C, et al. (2005) CD4+ T-cell death induced by infectious and noninfectious HIV-1: role of type 1 interferon-dependent, TRAIL/DR5-mediated apoptosis. Blood 106: 3524-3531.
34. Gasper-Smith N, Crossman DM, Whitesides JF, Mensali N, Ottinger JS, et al. (2008) Induction of plasma (TRAIL), TNFR-2, Fas ligand, and plasma microparticles after human immunodeficiency virus type 1 (HIV-1) transmission: implications for HIV-1 vaccine design. J Virol 82: 7700-7710.
35. Herbeuval JP, Nilsson J, Boasso A, Hardy AW, Vaccari M, et al. (2009) HAART reduces death ligand but not death receptors in lymphoid tissue of HIV-infected patients and simian immunodeficiency virus-infected macaques. Aids 23: 35-40.
36. Lichtner M, Maranon C, Vidalain PO, Azocar O, Hanau D, et al. (2004) HIV type 1-infected dendritic cells induce apoptotic death in infected and uninfected primary CD4 T lymphocytes. AIDS Res Hum Retroviruses 20: 175-182.
37. Martinez-Lorenzo MJ, Alava MA, Gamen S, Kim KJ, Chuntharapai A, et al. (1998) Involvement of APO2 ligand/TRAIL in activation-induced death of Jurkat and human peripheral blood T cells. Eur J Immunol 28: 2714-2725.
38. Monleon I, Martinez-Lorenzo MJ, Monteagudo L, Lasierra P, Taules M, et al. (2001) Differential secretion of Fas ligand- or APO2 ligand/TNF-related apoptosis-inducing ligand-carrying microvesicles during activation-induced death of human T cells. J Immunol 167: 6736-6744.
39. Chaperot L, Blum A, Manches O, Lui G, Angel J, et al. (2006) Virus or TLR agonists induce TRAIL-mediated cytotoxic activity of plasmacytoid dendritic cells. J Immunol 176: 248-255.
40. Hardy AW, Graham DR, Shearer GM, Herbeuval JP, (2007) HIV turns plasmacytoid dendritic cells (pDC) into TRAIL-expressing killer pDC and down-regulates HIV coreceptors by Toll-like receptor 7-induced IFN-alpha. Proc Natl Acad Sci U S A 104: 17453-17458.
41. Stary G, Klein I, Kohlhofer S, Koszik F, Scherzer T, et al. (2009) Plasmacytoid dendritic cells express TRAIL and induce CD4+ T-cell apoptosis in HIV-1 viremic patients. Blood 114: 3854-3863.
42. Herbeuval JP, Hardy AW, Boasso A, Anderson SA, Dolan MJ, et al. (2005) Regulation of TNF-related apoptosis-inducing ligand on primary CD4+ T cells by HIV-1: role of type I IFN-producing plasmacytoid dendritic cells. Proc Natl Acad Sci U S A 102: 13974-13979.
43. Roederer M, Treister A, Moore W, Herzenberg LA, (2001) Probability binning comparison: a metric for quantitating univariate distribution differences. Cytometry 45: 37-46.